Cargando…
Liraglutide + PYY(3-36) Combination Therapy Mimics Effects of Roux-en-Y Bypass on Early NAFLD Whilst Lacking-Behind in Metabolic Improvements
Background: Treatment options for NAFLD are still limited. Bariatric surgery, such as Roux-en-Y gastric bypass (RYGB), has been shown to improve metabolic and histologic markers of NAFLD. Glucagon-like-peptide-1 (GLP-1) analogues lead to improvements in phase 2 clinical trials. We directly compared...
Autores principales: | Metzner, Valentin, Herzog, Gloria, Heckel, Tobias, Bischler, Thorsten, Hasinger, Julia, Otto, Christoph, Fassnacht, Martin, Geier, Andreas, Seyfried, Florian, Dischinger, Ulrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836549/ https://www.ncbi.nlm.nih.gov/pubmed/35160204 http://dx.doi.org/10.3390/jcm11030753 |
Ejemplares similares
-
Toward a Medical Gastric Bypass: Chronic Feeding Studies With Liraglutide + PYY(3-36) Combination Therapy in Diet-Induced Obese Rats
por: Dischinger, Ulrich, et al.
Publicado: (2021) -
Roux-en-Y Gastric Bypass and Caloric Restriction but Not Gut Hormone-Based Treatments Profoundly Impact the Hypothalamic Transcriptome in Obese Rats
por: Dischinger, Ulrich, et al.
Publicado: (2021) -
Effects of 2 Novel PYY(1-36) Analogues,
(P(3)L(31)P(34))PYY(1-36) and
PYY(1-36)(Lys(12)PAL), on Pancreatic Beta-Cell Function, Growth,
and Survival
por: Lafferty, Ryan A, et al.
Publicado: (2019) -
SAT-607 The Vagus Nerve and the Hypothalamus Mediate Different Aspects of the Anorectic Effects of PYY(3-36)
por: Alonso, Aldara Martin, et al.
Publicado: (2020) -
Sitagliptin and Roux‐en‐Y gastric bypass modulate insulin secretion via regulation of intra‐islet PYY
por: Guida, Claudia, et al.
Publicado: (2017)